Trial Profile
A study to evaluate the treatment responders of topical brimonidine for the treatment of erythemato-telangiectatic rosacea measured by digital photography and videodermatoscopy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2016
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- 31 Mar 2016 New trial record
- 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology